Clinical Trials Directory

Trials / Unknown

UnknownNCT01341951

Granulocyte Colony Stimulating Factor (G-CSF) in Acute Liver Failure and Alcoholic Hepatitis

G-CSF in Acute Liver Failure and Alcoholic Hepatitis - A Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Granulocyte colony stimulating factor in acute liver failure and alcoholic hepatitis

Detailed description

In this study 4 groups have been taken. Two groups of cases including Alcoholic patients and acute liver failure which are given G-CSF therapy and two groups of controls given standard therapy. Primary end point is to see the mobilization of CD-34 hematopoietic cells and survival. Secondary end point is to see the clinical and biochemical improvement in liver functions.

Conditions

Interventions

TypeNameDescription
DRUGGranulocyte colony stimulating factor300 I.U twice daily for 5 days

Timeline

Start date
2010-06-01
Primary completion
2011-06-01
Completion
2011-06-01
First posted
2011-04-26
Last updated
2011-04-26

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01341951. Inclusion in this directory is not an endorsement.

Granulocyte Colony Stimulating Factor (G-CSF) in Acute Liver Failure and Alcoholic Hepatitis (NCT01341951) · Clinical Trials Directory